Bengaluru, August 2, 2020: The ethics committee of the Bangalore Medical College and Research Institute (BMCRI) has decided to suspend the clinical trials for ayurvedic tablets ’Bhoumya and Saathmya’ which were introduced to "cure" coronavirus.
The medicines were introduced by a Bengaluru-based ayurvedic medical practitioner named Dr Giridhar Kaje, who allegedly went to the media claiming the success of the trials without presenting it to the ethics committee, media reports said.
BMCRI, in a letter to Dr Kaje, said, "You are aware that the trial is still in its preliminary stage and no results have been placed before the ethics committee of BMCRI. Such being the factual position, you have gone to the public claiming success of the Trial. This is unacceptable and amounts to overstepping of one’s responsibility."
"You are called upon to immediately clarify in the media the factual position as otherwise we may be compelled to suspend the trial due to the unauthorised act of yours in misleading the public," the letter added.
The allegations have been denied by Dr Kaje, media reports said.
Last month, clinical trials for ayurvedic tablets were held between June 7 and 25 at the Victoria Hospital, which comes under BMCRI.
The trials were evaluating the efficacy and safety of both the tablets as an add-on therapy to the standard care given to Covid-positive patients, sources said.